- MyIllumina
- Tools
The TruSeq DNA Sample Preparation Kits v2 provide a simple, scalable, cost-effective solution for generating libraries from genomic DNA that is compatible with Illumina's unparalleled sequencing output. The kits feature 24 unique indexes, delivering enhanced multiplex performance for processing up to 384 samples on a single HiSeq 2000 run.
View the product support page for additional technical information ยป
Master-mixed reagents eliminate the majority of pipetting steps and reduce the amount of clean-up, as compared to previous methods, minimizing hands-on time. This results in economical, high-throughput DNA sequencing studies achieved with the easiest-to-use sample preparation workflow offered by any sequencing platform.
- The TruSeq DNA v2 Sample Preparation kit includes a gel-free protocol optimized for use with the TruSeq Exome Enrichment Kit and the TruSeq Custom Enrichment Kit
Learn more about TruSeq technology.
Catalog IDs: FC-121-2001, FC-121-2002
Product Literature
| TruSeq Exome Enrichment Kit Data Sheet |
| TruSeq Sample Prep Kits Data Sheet |
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.